Novartis
NVS
NVS
1,200 hedge funds and large institutions have $14.9B invested in Novartis in 2023 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 341 increasing their positions, 476 reducing their positions, and 68 closing their positions.
Holders
1,200
Holders Change
+20
Holders Change %
+1.69%
% of All Funds
18.93%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.21%
New
98
Increased
341
Reduced
476
Closed
68
Calls
$677M
Puts
$292M
Net Calls
+$384M
Net Calls Change
+$46.3M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1276
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
1277
Nomura Holdings
Tokyo,
Japan
| – | – | – | – |
|
1278
Holocene Advisors
New York
| – | – | – | – |
|
|
WVP
1279
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
1280
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
TSS
1281
Two Sigma Securities
New York
| – | – | – | – |
|
1282
Walleye Capital
New York
| – | – | – | – |
|
1283
Walleye Trading
New York
| – | – | – | – |
|